← back to search

Yuyan Liao

Columbia University · US
Area of research
Genetics · Oncology
Research interest
Research focused on Breast cancer and Prospective cohort study, with related work in Cancer, Body mass index, Hazard ratio. Notable publications include '10-year performance of four models of breast cancer risk: a validation study', 'Age-specific breast cancer risk by body mass index and familial risk: prospective family study cohort (ProF-SC)', and 'Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study'.
h-index
citations
530
works
10
NIH funding
primary concept
email

Recent publications

Abstract 4176: Timing of pregnancy-related factors and breast cancer risk for women across a range of absolute risk
Cancer Research 2023cited by 0position: middledoi
10-year performance of four models of breast cancer risk: a validation study
The Lancet Oncology 2019cited by 169position: middledoi
Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study
Breast Cancer Research 2019cited by 69position: middledoi
Alcohol consumption, cigarette smoking, and familial breast cancer risk: findings from the Prospective Family Study Cohort (ProF-SC)
Breast Cancer Research 2019cited by 54position: middledoi
Accuracy of Risk Estimates from the iPrevent Breast Cancer Risk Assessment and Management Tool
JNCI Cancer Spectrum 2019cited by 16position: middledoi
Age-specific breast cancer risk by body mass index and familial risk: prospective family study cohort (ProF-SC)
Breast Cancer Research 2018cited by 93position: middledoi
The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With BRCA1 or BRCA2 Mutations
JNCI Cancer Spectrum 2018cited by 33position: middledoi
Early life growth, socioeconomic status, and mammographic breast density in an urban US birth cohort
Annals of Epidemiology 2016cited by 15position: middledoi
Second primary breast cancer in BRCA1 and BRCA2 mutation carriers: 10-year cumulative incidence in the Breast Cancer Family Registry
Breast Cancer Research and Treatment 2015cited by 38position: middledoi
Global DNA methylation levels in white blood cell DNA from sisters discordant for breast cancer from the New York site of the Breast Cancer Family Registry
Epigenetics 2012cited by 43position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Mary Beth Terry · Columbia University Irving Medical Center9 papers (2012–2023)Esther M. John · Palo Alto University7 papers (2015–2023)Saundra S. Buys · University of Utah7 papers (2015–2023)Wendy K. Chung · Oregon Health & Science University6 papers (2015–2019)John L. Hopper · National Institute on Deafness and Other Communication Disorders6 papers (2018–2023)Irene L. Andrulis · University of Toronto6 papers (2015–2019)Melissa C. Southey · Monash Health6 papers (2015–2019)Julia A. Knight · Lunenfeld-Tanenbaum Research Institute6 papers (2015–2019)Graham G. Giles · Monash Institute of Medical Research5 papers (2018–2019)Roger L. Milne · Monash Institute of Medical Research5 papers (2018–2019) · 5 papers (2018–2019)Gord Glendon · Lunenfeld-Tanenbaum Research Institute5 papers (2018–2019)Robert J. MacInnis · Cancer Council Victoria5 papers (2018–2019) · 5 papers (2018–2019)Gillian S. Dite · Columbia University5 papers (2018–2019)Mary B. Daly · Fox Chase Cancer Center5 papers (2018–2019)Michael Friedländer · University of South Wales4 papers (2018–2019)Nur Zeinomar · Columbia University4 papers (2018–2019)Kelly‐Anne Phillips · University of Alabama4 papers (2019–2019)Jeanine M. Genkinger · Columbia University Irving Medical Center3 papers (2018–2023)